HEADER TRANSCRIPTION 16-MAR-07 2EJE TITLE SOLUTION STRUCTURE OF RSGI RUH-071, A GTF2I DOMAIN IN HUMAN CDNA COMPND MOL_ID: 1; COMPND 2 MOLECULE: GENERAL TRANSCRIPTION FACTOR II-I; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: GTF2I LIKE 6 DOMAIN; COMPND 5 SYNONYM: GTFII-I, TFII-I, BRUTON TYROSINE KINASE-ASSOCIATED PROTEIN COMPND 6 135, BTK-ASSOCIATED PROTEIN 135, BAP-135, SRF-PHOX1-INTERACTING COMPND 7 PROTEIN, SPIN, WILLIAMS-BEUREN SYNDROME CHROMOSOME REGION 6 PROTEIN, COMPND 8 RSGI RUH-071; COMPND 9 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: AAC08312; SOURCE 6 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 7 EXPRESSION_SYSTEM_PLASMID: P051011-01; SOURCE 8 OTHER_DETAILS: CELL-FREE PROTEIN SYNTHESIS (E. COLI) KEYWDS TRANSCRIPTION FACTOR, STRUCTURAL GENOMICS, NPPSFA, NATIONAL PROJECT KEYWDS 2 ON PROTEIN STRUCTURAL AND FUNCTIONAL ANALYSES, RIKEN STRUCTURAL KEYWDS 3 GENOMICS/PROTEOMICS INITIATIVE, RSGI, TRANSCRIPTION EXPDTA SOLUTION NMR NUMMDL 20 AUTHOR Y.DOI-KATAYAMA,H.HIROTA,F.HAYASHI,S.YOKOYAMA,RIKEN STRUCTURAL AUTHOR 2 GENOMICS/PROTEOMICS INITIATIVE (RSGI) REVDAT 3 09-MAR-22 2EJE 1 REMARK SEQADV REVDAT 2 24-FEB-09 2EJE 1 VERSN REVDAT 1 18-SEP-07 2EJE 0 JRNL AUTH Y.DOI-KATAYAMA,H.HIROTA,F.HAYASHI,S.YOKOYAMA JRNL TITL SOLUTION STRUCTURE OF RSGI RUH-071, A GTF2I DOMAIN IN HUMAN JRNL TITL 2 CDNA JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : VNMR 6.1C, CYANA 1.0.7 REMARK 3 AUTHORS : VARIAN (VNMR), GUNTERT, P. (CYANA) REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2EJE COMPLIES WITH FORMAT V. 3.15, 01-DEC-08 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 24-APR-07. REMARK 100 THE DEPOSITION ID IS D_1000026736. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 298 REMARK 210 PH : 7.0 REMARK 210 IONIC STRENGTH : 120MM NACL REMARK 210 PRESSURE : AMBIENT REMARK 210 SAMPLE CONTENTS : 1.30MM GTF2I DOMAIN U-15N, 13C; REMARK 210 20MM D-TRIS-HCL(PH 7.0); 100MM REMARK 210 NACL; 1MM D-DTT; 0.02% NAN3; 90% REMARK 210 H2O, 10% D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 3D_15N-SEPARATED_NOESY; 3D_13C REMARK 210 -SEPARATED_NOESY REMARK 210 SPECTROMETER FIELD STRENGTH : 900 MHZ; 800 MHZ REMARK 210 SPECTROMETER MODEL : INOVA REMARK 210 SPECTROMETER MANUFACTURER : VARIAN REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : NMRPIPE 20020425, NMRVIEW 5.0.4, REMARK 210 KUJIRA 0.9747, CYANA 1.0.7 REMARK 210 METHOD USED : TORSION ANGLE DYNAMICS REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 100 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 20 REMARK 210 CONFORMERS, SELECTION CRITERIA : STRUCTURES WITH THE LEAST REMARK 210 RESTRAINT VIOLATIONS, STRUCTURES REMARK 210 WITH THE LOWEST ENERGY, TARGET REMARK 210 FUNCTION REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O ASP A 28 H ARG A 32 1.52 REMARK 500 O LEU A 84 H ALA A 87 1.52 REMARK 500 O VAL A 16 H ARG A 20 1.55 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 ASP A 9 124.30 167.50 REMARK 500 1 LEU A 13 -104.84 -55.52 REMARK 500 1 SER A 14 -71.34 78.48 REMARK 500 1 ASN A 54 122.43 -177.57 REMARK 500 1 CYS A 57 -77.02 -53.90 REMARK 500 1 MET A 63 143.36 -39.60 REMARK 500 1 ASN A 104 173.02 73.19 REMARK 500 1 ASN A 105 -175.03 63.31 REMARK 500 1 LEU A 107 -174.50 -65.27 REMARK 500 1 SER A 112 -87.33 -151.35 REMARK 500 2 SER A 3 143.84 65.82 REMARK 500 2 ASP A 9 93.77 50.83 REMARK 500 2 LEU A 13 -106.61 -56.38 REMARK 500 2 SER A 14 -71.45 76.60 REMARK 500 2 ASN A 54 120.69 -179.77 REMARK 500 2 CYS A 57 -85.20 -54.24 REMARK 500 2 MET A 63 140.40 -37.57 REMARK 500 2 LYS A 70 165.93 177.86 REMARK 500 2 ALA A 71 150.90 -44.22 REMARK 500 2 VAL A 94 76.82 -109.80 REMARK 500 2 ILE A 103 56.74 -118.92 REMARK 500 2 ASN A 105 75.82 -64.59 REMARK 500 2 LEU A 107 174.59 -57.54 REMARK 500 2 VAL A 108 89.81 -154.24 REMARK 500 2 SER A 109 121.58 61.10 REMARK 500 2 SER A 113 38.83 177.57 REMARK 500 3 SER A 2 -85.31 61.90 REMARK 500 3 SER A 3 158.86 74.50 REMARK 500 3 SER A 5 -63.48 -176.29 REMARK 500 3 SER A 6 171.45 61.83 REMARK 500 3 ASP A 8 -49.19 -161.85 REMARK 500 3 LEU A 13 -98.27 -50.27 REMARK 500 3 SER A 14 -71.67 75.88 REMARK 500 3 CYS A 57 -89.27 -54.68 REMARK 500 3 LYS A 70 166.57 177.79 REMARK 500 3 ALA A 71 151.52 -45.95 REMARK 500 3 ILE A 90 151.01 -41.48 REMARK 500 3 GLN A 106 155.83 174.35 REMARK 500 3 LEU A 107 -168.42 44.67 REMARK 500 3 VAL A 108 72.01 40.18 REMARK 500 3 SER A 109 -61.90 -90.62 REMARK 500 3 PRO A 111 -166.35 -74.99 REMARK 500 3 SER A 112 39.22 -90.14 REMARK 500 3 SER A 113 41.47 -179.19 REMARK 500 4 SER A 2 -58.53 -142.50 REMARK 500 4 SER A 6 -58.40 -177.97 REMARK 500 4 ASP A 8 -179.06 -176.75 REMARK 500 4 LEU A 13 -101.42 -53.14 REMARK 500 4 SER A 14 -71.53 81.42 REMARK 500 4 CYS A 57 -80.34 -53.84 REMARK 500 REMARK 500 THIS ENTRY HAS 284 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 650 REMARK 650 HELIX REMARK 650 DETERMINATION METHOD: AUTHOR DETERMINED REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: HSO002001981.4 RELATED DB: TARGETDB DBREF 2EJE A 8 108 UNP P78347 GTF2I_HUMAN 854 954 SEQADV 2EJE GLY A 1 UNP P78347 EXPRESSION TAG SEQADV 2EJE SER A 2 UNP P78347 EXPRESSION TAG SEQADV 2EJE SER A 3 UNP P78347 EXPRESSION TAG SEQADV 2EJE GLY A 4 UNP P78347 EXPRESSION TAG SEQADV 2EJE SER A 5 UNP P78347 EXPRESSION TAG SEQADV 2EJE SER A 6 UNP P78347 EXPRESSION TAG SEQADV 2EJE GLY A 7 UNP P78347 EXPRESSION TAG SEQADV 2EJE SER A 109 UNP P78347 EXPRESSION TAG SEQADV 2EJE GLY A 110 UNP P78347 EXPRESSION TAG SEQADV 2EJE PRO A 111 UNP P78347 EXPRESSION TAG SEQADV 2EJE SER A 112 UNP P78347 EXPRESSION TAG SEQADV 2EJE SER A 113 UNP P78347 EXPRESSION TAG SEQADV 2EJE GLY A 114 UNP P78347 EXPRESSION TAG SEQRES 1 A 114 GLY SER SER GLY SER SER GLY ASP ASP ASN GLU ARG LEU SEQRES 2 A 114 SER LYS VAL GLU LYS ALA ARG GLN LEU ARG GLU GLN VAL SEQRES 3 A 114 ASN ASP LEU PHE SER ARG LYS PHE GLY GLU ALA ILE GLY SEQRES 4 A 114 MET GLY PHE PRO VAL LYS VAL PRO TYR ARG LYS ILE THR SEQRES 5 A 114 ILE ASN PRO GLY CYS VAL VAL VAL ASP GLY MET PRO PRO SEQRES 6 A 114 GLY VAL SER PHE LYS ALA PRO SER TYR LEU GLU ILE SER SEQRES 7 A 114 SER MET ARG ARG ILE LEU ASP SER ALA GLU PHE ILE LYS SEQRES 8 A 114 PHE THR VAL ILE ARG PRO PHE PRO GLY LEU VAL ILE ASN SEQRES 9 A 114 ASN GLN LEU VAL SER GLY PRO SER SER GLY HELIX 1 1 LYS A 15 ALA A 37 1 23 HELIX 2 2 TYR A 48 ILE A 53 1 6 HELIX 3 3 ILE A 77 ASP A 85 1 9 SHEET 1 A 2 VAL A 58 ASP A 61 0 SHEET 2 A 2 LYS A 91 VAL A 94 -1 O THR A 93 N VAL A 59 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1 MODEL 2 MODEL 3 MODEL 4 MODEL 5 MODEL 6 MODEL 7 MODEL 8 MODEL 9 MODEL 10 MODEL 11 MODEL 12 MODEL 13 MODEL 14 MODEL 15 MODEL 16 MODEL 17 MODEL 18 MODEL 19 MODEL 20